Genetic testing on embryos is more sophisticated and accessible than ever—and it’s now being sold as a way to let parents ...

Toronto, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Juniper Genomics, a health-tech company pioneering a new standard of care in IVF, today announced its public launch alongside a $4.6 million seed ...

Screening embryos during in-vitro fertilization to select those with fewer genetic risks for common diseases and certain physical traits is technologically and ethically questionable, a group of ...

“Predictive indicators for whether a child will be vulnerable to certain diseases after birth, as well as their future height and skin tone, are becoming increasingly sophisticated. Hospitals that ...

(MENAFN- GlobeNewsWire - Nasdaq) Backed by $4.6M in seed funding, Juniper is looking to define a new clinical standard of care for IVF genetic testing Toronto, Ontario, June 26, 2025 (GLOBE NEWSWIRE) ...

Orchid Fertility Dubai is at the forefront of reproductive technology with an innovative answer to one of the biggest challenges in assisted reproduction—i.e., the selection of the healthiest embryos ...

Orchidという米国のスタートアップが、子どもが将来的に特定の病気にかかる可能性を両親の唾液から調べるという遺伝子診断サーヴィスをこのほど発表した。父親と母親の唾液のサンプルを送付すると、ふたりの未来の子どもについて、アルツハイマー病や ...